Valuation (81%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.13 | N/A |
| PEG Ratio (TTM) | 3.43 | N/A |
| P/S Ratio (TTM) | 0.56 | N/A |
| P/B Ratio (TTM) | 1.40 | N/A |
| P/FCF Ratio (TTM) | 18.02 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.36 | N/A |
| Price to 5YR AVG FCF Ratio | 9.29 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.94% | N/A |
| ROE (TTM) | 12.89% | N/A |
| Net Profit Margin (TTM) | 4.81% | N/A |
| ROIC 5YR AVG | 12.43% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 12.29% | 72.38% | 40.80% |
| Revenue | 2.34% | 11.87% | 4.44% |
| Net Income | 8.54% | 73.05% | 37.49% |
| Cash Flow | 469.54% | 23.29% | 4.69% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.53 | N/A |
| Quick Ratio (TTM) | 1.14 | N/A |
| D/E Ratio (TTM) | 1.32 | N/A |
| Interest Coverage (TTM) | 3.48 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.55 | N/A |
| LTL to 5YR AVG FCF | 8.67 | N/A |
| Shares Outstanding Growth 5YR AVG | -4.06% | N/A |